Vir Biotechnology (VIR) Revenue (2018 - 2026)
Vir Biotechnology's Revenue was $238.95 million in Q2 2026, compared with $1.21 million a year earlier.
Powered by 
Analysis
Vir Biotechnology (VIR) Revenue (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vir Biotechnology's Revenue was $303.29 million through Jun 30, 2026; for FY2025, it came in at $68.56 million, down 7.6% from FY2024.
- Revenue has now declined for three consecutive years, with a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
- In earlier years, Revenue was $74.21 million in FY2024 (-13.9%), $86.18 million in FY2023 (-94.7%), $1.62 billion in FY2022 (+47.5%) and $1.1 billion in FY2021.
- The Q2 2026 figure marks the highest quarterly Revenue since Q3 2022.
- Compared with a year earlier, Revenue was higher in 1 of the last seven quarters, with growth averaging 5.4%.
- The best year-over-year quarter for Revenue over five years was Q4 2025 (growth of 417.8%); the worst was Q3 2023 (a decline of 99.3%).
- Per Business Quant data, VIR's Revenue in the three quarters before Q2 2026 was $29,000 (Q1 2026), $64.07 million (Q4 2025) and $240,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Vir Biotechnology | 1.78 Bn | 1.78 Bn | 238.95 Mn | 238.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 238.95 Mn |
| Mar 31, 2026 | 29,000.00 |
| Dec 31, 2025 | 64.07 Mn |
| Sep 30, 2025 | 240,000.00 |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | 12.37 Mn |
| Sep 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 56.38 Mn |
| Dec 31, 2023 | 16.79 Mn |
| Sep 30, 2023 | 2.64 Mn |
| Jun 30, 2023 | 3.80 Mn |
| Mar 31, 2023 | 62.96 Mn |
| Dec 31, 2022 | 49.41 Mn |
| Sep 30, 2022 | 374.56 Mn |
| Jun 30, 2022 | 40.63 Mn |
| Mar 31, 2022 | 1.23 Bn |
| Dec 31, 2021 | 812.75 Mn |
| Sep 30, 2021 | 103.62 Mn |
API Access
Vir Biotechnology Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();